PortfoliosLab logo
Evolent Health, Inc. (EVH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US30050B1017

CUSIP

30050B101

IPO Date

Jun 5, 2015

Highlights

Market Cap

$1.16B

EPS (TTM)

-$0.81

PEG Ratio

-1.37

Total Revenue (TTM)

$1.92B

Gross Profit (TTM)

$233.08M

EBITDA (TTM)

$65.68M

Year Range

$8.35 - $33.63

Target Price

$15.15

Short %

15.70%

Short Ratio

7.08

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Evolent Health, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%200.00%December2025FebruaryMarchAprilMay
-43.32%
171.72%
EVH (Evolent Health, Inc.)
Benchmark (^GSPC)

Returns By Period

Evolent Health, Inc. (EVH) returned -4.98% year-to-date (YTD) and -61.00% over the past 12 months.


EVH

YTD

-4.98%

1M

6.16%

6M

-54.43%

1Y

-61.00%

5Y*

9.46%

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.31%

1M

0.28%

6M

-0.74%

1Y

12.29%

5Y*

15.01%

10Y*

10.56%

*Annualized

Monthly Returns

The table below presents the monthly returns of EVH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-7.11%-13.97%5.34%4.12%8.42%-4.98%
2024-10.96%15.30%-3.30%-15.40%-23.61%-9.77%21.97%37.14%-11.57%-17.43%-44.67%-12.93%-65.94%
202314.74%8.66%-7.31%12.20%-19.97%3.98%0.30%-16.06%6.74%-10.28%13.79%18.81%17.63%
2022-14.31%12.40%21.20%-14.80%2.22%9.17%10.68%8.12%-2.23%-11.47%-9.49%-2.47%1.48%
20216.49%18.04%0.25%7.23%-10.30%8.70%8.62%7.06%26.22%-5.58%-11.17%6.42%72.61%
202011.38%-8.33%-41.23%32.78%23.16%-19.82%63.62%23.00%-13.40%-19.90%46.18%10.32%77.13%
2019-11.38%-25.40%-4.62%7.71%-21.48%-25.28%-14.21%0.73%4.66%5.98%-5.38%25.52%-54.64%
201814.63%3.90%-2.73%15.79%23.94%2.93%-4.04%26.24%11.37%-21.83%15.77%-22.37%62.20%
201722.97%8.24%13.20%4.26%-1.29%10.46%-2.56%-32.39%6.59%-8.71%-20.92%-4.28%-16.89%
2016-18.50%1.82%5.07%13.73%27.56%25.33%22.60%5.65%-1.01%-14.50%-10.69%-21.28%22.21%
20153.39%9.38%-20.30%-6.12%-19.49%26.69%-25.61%-35.79%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of EVH is 11, meaning it’s performing worse than 89% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of EVH is 1111
Overall Rank
The Sharpe Ratio Rank of EVH is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of EVH is 1212
Sortino Ratio Rank
The Omega Ratio Rank of EVH is 1010
Omega Ratio Rank
The Calmar Ratio Rank of EVH is 66
Calmar Ratio Rank
The Martin Ratio Rank of EVH is 1616
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Evolent Health, Inc. (EVH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for EVH, currently valued at -0.80, compared to the broader market-2.00-1.000.001.002.003.00
EVH: -0.80
^GSPC: 0.67
The chart of Sortino ratio for EVH, currently valued at -1.01, compared to the broader market-6.00-4.00-2.000.002.004.00
EVH: -1.01
^GSPC: 1.05
The chart of Omega ratio for EVH, currently valued at 0.84, compared to the broader market0.501.001.502.00
EVH: 0.84
^GSPC: 1.16
The chart of Calmar ratio for EVH, currently valued at -0.78, compared to the broader market0.001.002.003.004.005.00
EVH: -0.78
^GSPC: 0.68
The chart of Martin ratio for EVH, currently valued at -1.26, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
EVH: -1.26
^GSPC: 2.70

The current Evolent Health, Inc. Sharpe ratio is -0.80. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Evolent Health, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.80
0.67
EVH (Evolent Health, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Evolent Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-73.10%
-7.45%
EVH (Evolent Health, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Evolent Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Evolent Health, Inc. was 87.34%, occurring on Mar 16, 2020. Recovery took 389 trading sessions.

The current Evolent Health, Inc. drawdown is 73.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.34%Sep 26, 2018369Mar 16, 2020389Sep 29, 2021758
-78.66%Sep 13, 2022653Apr 21, 2025
-62.34%Aug 6, 2015138Feb 23, 201699Jul 14, 2016237
-61.61%Jun 9, 2017111Nov 14, 2017208Sep 13, 2018319
-44.55%Aug 12, 201697Dec 29, 2016109Jun 7, 2017206

Volatility

Volatility Chart

The current Evolent Health, Inc. volatility is 16.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%December2025FebruaryMarchAprilMay
16.26%
14.17%
EVH (Evolent Health, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Evolent Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Evolent Health, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -260.0%.

-0.200.000.200.400.6020212022202320242025
-0.02
0.24
Actual
Estimate

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items